News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
101,665 Results
Type
Article (3061)
Company Profile (13)
Press Release (98591)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (36452)
Career Advice (67)
Deals (6133)
Drug Delivery (13)
Drug Development (11919)
Employer Resources (13)
FDA (1955)
Job Trends (2376)
News (54130)
Policy (3035)
Tag
Academia (236)
Accelerated approval (10)
Allergies (39)
Alliances (3643)
ALS (53)
Alzheimer's disease (268)
Antibody-drug conjugate (ADC) (115)
Approvals (2166)
Artificial intelligence (194)
Autoimmune disease (53)
Automation (17)
Bankruptcy (55)
Best Places to Work (2395)
BIOSECURE Act (3)
Biosimilars (63)
Biotechnology (11)
Bladder cancer (94)
Brain cancer (12)
Breast cancer (283)
Cancer (1851)
Cardiovascular disease (153)
Career advice (66)
Career pathing (3)
CAR-T (84)
CDC (4)
Cell therapy (224)
Cervical cancer (20)
Clinical research (12432)
Collaboration (647)
Company closure (1)
Compensation (685)
Complete response letters (6)
COVID-19 (317)
CRISPR (31)
C-suite (273)
Cystic fibrosis (44)
Data (2373)
Depression (28)
Diabetes (134)
Diagnostics (1099)
Digital health (14)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (85)
Drug pricing (20)
Drug shortages (3)
Duchenne muscular dystrophy (69)
Earnings (32967)
Editorial (4)
Employer branding (1)
Employer resources (10)
Events (13315)
Executive appointments (385)
FDA (3209)
Fibrodysplasia Ossificans Progressiva (3)
Frontotemporal dementia (11)
Funding (539)
Gene editing (63)
Generative AI (8)
Gene therapy (170)
GLP-1 (234)
Government (403)
Grass and pollen (3)
Guidances (312)
Healthcare (2929)
HIV (30)
Huntington's disease (12)
IgA nephropathy (42)
Immunology and inflammation (44)
Immuno-oncology (19)
Indications (42)
Infectious disease (410)
Inflammatory bowel disease (41)
Inflation Reduction Act (2)
Influenza (33)
Intellectual property (57)
Interviews (7)
IPO (4725)
IRA (3)
Job creations (259)
Job search strategy (55)
JPM (2)
Kidney cancer (7)
Labor market (13)
Layoffs (44)
Leadership (2)
Legal (528)
Liver cancer (26)
Longevity (2)
Lung cancer (279)
Lymphoma (159)
Machine learning (14)
Management (5)
Manufacturing (204)
MASH (53)
Medical device (2402)
Medtech (2419)
Mergers & acquisitions (1789)
Metabolic disorders (350)
Multiple sclerosis (46)
NASH (5)
Neurodegenerative disease (92)
Neuropsychiatric disorders (28)
Neuroscience (633)
NextGen: Class of 2026 (744)
Non-profit (553)
Now hiring (3)
Obesity (168)
Opinion (10)
Ovarian cancer (61)
Pain (44)
Pancreatic cancer (59)
Parkinson's disease (76)
Patents (98)
Patient recruitment (162)
Peanut (18)
People (4174)
Pharmaceutical (6)
Pharmacy benefit managers (5)
Phase 1 (3287)
Phase 2 (5127)
Phase 3 (4899)
Pipeline (2557)
Policy (16)
Postmarket research (438)
Preclinical (982)
Press Release (2)
Prostate cancer (101)
Psychedelics (10)
Radiopharmaceuticals (43)
Rare diseases (225)
Real estate (363)
Recruiting (2)
Regulatory (3218)
Reports (16)
Research institute (225)
Resumes & cover letters (4)
Rett syndrome (19)
RNA editing (1)
RSV (37)
Schizophrenia (45)
Series A (70)
Series B (76)
Sickle cell disease (27)
Special edition (3)
Spinal muscular atrophy (13)
Sponsored (3)
Startups (213)
Stomach cancer (1)
Supply chain (36)
Tariffs (4)
The Weekly (4)
Vaccines (170)
Venture capital (21)
Weight loss (86)
Women's health (31)
Worklife (2)
Date
Last 7 days (237)
Last 30 days (735)
Last 365 days (11774)
2026 (1223)
2025 (12049)
2024 (8882)
2023 (7228)
2022 (8670)
2021 (8987)
2020 (8239)
2019 (6997)
2018 (5162)
2017 (4301)
2016 (3450)
2015 (4307)
2014 (2820)
2013 (1766)
2012 (2103)
2011 (2551)
2010 (2402)
Location
Africa (68)
Alabama (16)
Arizona (36)
Arkansas (4)
Asia (5470)
Australia (792)
California (4803)
Canada (1008)
China (302)
Colorado (181)
Connecticut (209)
Delaware (208)
Europe (14384)
Florida (437)
Georgia (118)
Hawaii (3)
Idaho (8)
Illinois (346)
India (16)
Indiana (133)
Iowa (7)
Japan (231)
Kansas (15)
Kentucky (14)
Louisiana (11)
Maine (15)
Maryland (403)
Massachusetts (3507)
Michigan (121)
Minnesota (222)
Mississippi (1)
Missouri (49)
Montana (4)
Nebraska (3)
Nevada (51)
New Hampshire (25)
New Jersey (1195)
New Mexico (7)
New York (1019)
North Carolina (441)
North Dakota (2)
Northern California (2335)
Ohio (114)
Oklahoma (6)
Oregon (6)
Pennsylvania (638)
Puerto Rico (2)
Rhode Island (14)
South America (111)
South Carolina (6)
Southern California (1862)
Tennessee (71)
Texas (675)
United States (15256)
Utah (86)
Vermont (1)
Virginia (105)
Washington D.C. (18)
Washington State (334)
West Virginia (3)
Wisconsin (87)
101,665 Results for "36".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
February 12, 2026
·
1 min read
Press Releases
Ascletis Selects Oral Amylin Receptor Peptide Agonist, ASC36, for Clinical Development
February 11, 2026
·
4 min read
Press Releases
Ligand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 4, 2026
·
2 min read
Press Releases
Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 5, 2026
·
4 min read
Press Releases
Catheter Precision, Inc. Secures up to $36.5 Million in Strategic Institutional Financing to Accelerate Growth
February 12, 2026
·
2 min read
Press Releases
Nxera Pharma to Receive US$3.6 Million in Milestone Payment Pursuant to Research Collaboration with Centessa
January 13, 2026
·
2 min read
Press Releases
K36 Therapeutics Completes Dosing of First Cohort in Phase 1 Clinical Trial of KTX-2001 in Prostate Cancer, Announces New CMO
February 5, 2026
·
3 min read
Press Releases
Daré Bioscience Receives $3.6 Million in Additional Grant Funding
November 24, 2025
·
10 min read
Press Releases
DISCO Pharmaceuticals Appoints Mark Manfredi as CEO and Announces Final Close of €36 Million Seed Financing
December 11, 2025
·
3 min read
Press Releases
Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Maintenance Period for its REZOLVE-AD Phase 2b Study of Rezpegaldesleukin in Atopic Dermatitis on February 10, 2026
February 10, 2026
·
2 min read
1 of 10,167
Next
